Literature DB >> 3190811

Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation.

R Dietrich1, R Brausse, G Benedikt, V W Steinijans.   

Abstract

This contribution attempts to relate the in-vitro drug release properties of theophylline from Euphylong pellets to serum theophylline concentration/time curves. Comparisons are made according to methods presented in recent publications (e.g. using mean residence time) and by juxtaposition of analogous values. For this, the mutual relationship of equal release times (absorption) and % amounts released or absorbed at fixed times are evaluated. The in-vitro data required for the computational evaluations were obtained using a paddle apparatus (according to USP XXI) at 100 rpm, buffer pH 7.4. The feasibility of converting the in-vitro to the in-vivo curve by means of a chronological transformation is examined, as well as in-vitro/in-vivo dependence on numerically fitted model parameters. Finally, in an attempt to imitate the in-vivo curve profile, the apparatus parameters for the in-vitro tests were subjected to extreme variation. The effect of the presence or absence of sink conditions is discussed and evaluated. In the concluding overview, the feasibility of predicting the in vivo behaviour of Euphylong pellets on the basis of current so-called "in-vitro/in-vivo correlation" procedures is assessed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190811

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  Effect of destruction force on drug release from multiple unit controlled release dosage forms in humans.

Authors:  N Katori; W S Ma; N Aoyagi; S Kojima
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

Review 2.  Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations.

Authors:  B Oosterhuis; J H Jonkman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

3.  The controlled release of prednisolone using alginate gel.

Authors:  S Sugawara; T Imai; M Otagiri
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

4.  Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.

Authors:  N Katori; N Aoyagi; T Terao
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

5.  Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.

Authors:  M Shameem; N Katori; N Aoyagi; S Kojima
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.